Lassmann-Vague V
Service de Nutrition-Maladies Métaboliques-Endocrinologie, CHU La Timone, Marseille, France.
Diabete Metab. 1994;20(2 Pt 2):206-10.
Ideally, insulin administration should be done through portal route, with a precise kinetic. It should also lead to a reproducible biologic effect, with minimal side-effects and be acceptable for the majority of diabetic patients. Many alternative routes of insulin administration try to fulfill one or more of these criteria. Intraperitoneal route is already used with implantable pumps. It has proven safety and metabolic efficacy, particularly upon the reduction of severe hypoglycaemia. Nasal route could provide a rapid kinetic, but its long-term utilisation depends on improvement of bioavailability and studies of local toxicity. Results concerning intrabronchic insulin seem promising, but are still preliminary. In the future, the choice among these alternative routes of insulin administration will be guided by the development of a closed-loop system.
理想情况下,胰岛素应通过门静脉途径给药,具有精确的动力学特性。它还应产生可重复的生物学效应,副作用最小,并且大多数糖尿病患者都能接受。许多胰岛素给药的替代途径试图满足这些标准中的一项或多项。腹腔内途径已用于植入式泵。它已被证明具有安全性和代谢功效,特别是在降低严重低血糖方面。鼻内途径可以提供快速的动力学特性,但其长期使用取决于生物利用度的提高和局部毒性研究。关于支气管内胰岛素的结果似乎很有前景,但仍处于初步阶段。未来,这些胰岛素给药替代途径的选择将由闭环系统的发展来指导。